CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion
- PMID: 22552741
- DOI: 10.3892/ijo.2012.1453
CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion
Abstract
The metastatic process involves the migration and invasion of cancer cells throughout the body to produce secondary tumors at distant sites. Through of epithelial-mesenchymal transition (EMT), cancer cells employ developmental processes to gain migratory and invasive properties. CD44 is the transmembrane adhesion receptor for Hyaluronan (HA) and plays a central role in the remodeling and degradation of HA that leads to cell migration, as well as to cancer invasion and metastasis. CD44 is highly expressed in primary and metastatic colon cancer but lowly expressed in normal tissues. We evaluated the impact of CD44 on EMT and invasion of colon cancer cells. The functional role of CD44 in EMT was determined by the overexpression or knockdown of CD44. CD44 was overexpressed by transfection with plasmid-RT-PCR product and knockdown of CD44 by small hairpin RNA (shRNA)-mediated depletion of CD44 in SW480 colon cancer cells. Morphological changes were evaluated by confocal laser microscopy in the culture media. The expression of EMT markers (E-cadherin/N-cadherin/vimentin/fibronectin/actin/MMPs) and CD44/EGFR/PI3K-Akt signaling were evaluated using western blotting. The influence of EMT in tumor biology was assessed with proliferation, migration and invasion assays. EMT changes increased in CD44-overexpressing SW480 cells and decreased in CD44 knockdown cells. CD44 activation induced expression of EGFR and activation of phosphatidylinositol 3' kinase (PI3K)/Akt and expression of glycogen synthase kinase-3 β (GSK-3β). In terms of EMT markers, CD44 downregulated E-cadherin expression, upregulated N-cadherin, α-actin, vimentin, fibronectin and MT1-MMP, and inhibited the formation of the membrane-associated E-cadherin-β-catenin complex, which resulted in cell invasion and migration.
Similar articles
-
Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin.J Cell Biochem. 2011 Sep;112(9):2508-17. doi: 10.1002/jcb.23175. J Cell Biochem. 2011. PMID: 21557297
-
FMNL2 enhances invasion of colorectal carcinoma by inducing epithelial-mesenchymal transition.Mol Cancer Res. 2010 Dec;8(12):1579-90. doi: 10.1158/1541-7786.MCR-10-0081. Epub 2010 Nov 11. Mol Cancer Res. 2010. PMID: 21071512
-
Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.Oncol Rep. 2012 Nov;28(5):1808-14. doi: 10.3892/or.2012.1993. Epub 2012 Aug 24. Oncol Rep. 2012. PMID: 22922740
-
Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.Cells Tissues Organs. 2007;185(1-3):85-94. doi: 10.1159/000101307. Cells Tissues Organs. 2007. PMID: 17587812 Review.
-
Colon cancer at the molecular level--usefulness of epithelial-mesenchymal transition analysis.Rev Med Chir Soc Med Nat Iasi. 2012 Oct-Dec;116(4):1106-11. Rev Med Chir Soc Med Nat Iasi. 2012. PMID: 23700897 Review.
Cited by
-
CD44 correlates with clinicopathological characteristics and is upregulated by EGFR in breast cancer.Int J Oncol. 2016 Oct;49(4):1343-50. doi: 10.3892/ijo.2016.3639. Epub 2016 Jul 29. Int J Oncol. 2016. PMID: 27499099 Free PMC article.
-
RNA-binding proteins regulating the CD44 alternative splicing.Front Mol Biosci. 2023 Dec 1;10:1326148. doi: 10.3389/fmolb.2023.1326148. eCollection 2023. Front Mol Biosci. 2023. PMID: 38106992 Free PMC article. Review.
-
Clinicopathological significance and prognostic implication of CD44 and its splice variants (v3 and v6) in colorectal cancer.Transl Cancer Res. 2020 Feb;9(2):1215-1224. doi: 10.21037/tcr.2020.02.12. Transl Cancer Res. 2020. PMID: 35117466 Free PMC article.
-
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.Mol Cancer. 2019 May 20;18(1):96. doi: 10.1186/s12943-019-1023-1. Mol Cancer. 2019. PMID: 31109321 Free PMC article.
-
Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease.J Clin Endocrinol Metab. 2014 Jul;99(7):E1173-82. doi: 10.1210/jc.2013-4140. Epub 2014 Mar 21. J Clin Endocrinol Metab. 2014. PMID: 24654752 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous